Xospata label. Find steps for getting XOSPATA® (gilteritinib) filled at a specialty pharmacy and sent straight to your home. Find downloadable resources about XOSPATA® (gilteritinib) for patients, caregivers, and loved ones. Discover XOSPATA® (gilteritinib), a treatment for FLT3 mutation‐positive relapsed or refractory (R/R) acute myeloid leukemia (AML). Discover XOSPATA® (gilteritinib), a treatment for FLT3 mutation‐positive relapsed or refractory (R/R) acute myeloid leukemia (AML). XOSPATA is a prescription medicine used to treat adults with acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation when the disease has come back or has not improved after previous treatment(s). Learn about XOSPATA® (gilteritinib) dosing and administration information. . Your healthcare provider may tell you to decrease your dose, temporarily stop, or completely stop taking XOSPATA if you develop certain side effects during treatment with XOSPATA. Traditional chemotherapy works by killing fast-growing cells, which can include cancer cells and other types of cells. Find Indication and Important Safety Information for XOSPATA® (gilteritinib), including BOXED WARNING. See Important Safety Information including BOXED WARNING. XOSPATA is a targeted therapy and works differently than traditional chemotherapy. These are not all of the possible side effects of XOSPATA. Call your doctor for medical advice about side effects. Targeted therapies are designed to target certain features of cancer cells, like mutations. iin ict bcy zzk zdb aff voz otq wze jwp slg nvi opl xjr ekb